Search Results for "paritaprevir"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for paritaprevir. Results 1 to 3 of 3 total matches.
See also: Viekira Pak

Table: Inhibitors and Inducers of CYP Enzymes, P-Glycoprotein, and Other Transporters (online only)

   
The Medical Letter on Drugs and Therapeutics • Feb 06, 2023  (Issue 1669)
glecaprevir ledipasvir leflunomide letermovir lopinavir/ritonavir paritaprevir pibrentasvir rifampin ...
View the Inhibitors and Inducers of CYP Enzymes, P-Glycoprotein, and Other Transporters tables
Med Lett Drugs Ther. 2023 Feb 6;65(1669):e28-30   doi:10.58347/tml.2023.1669g |  Show IntroductionHide Introduction

Twirla - A New Contraceptive Patch

   
The Medical Letter on Drugs and Therapeutics • Feb 08, 2021  (Issue 1617)
containing ombitasvir/paritaprevir/ ritonavir (Viekira Pak, Technivie) can increase alanine ...
The FDA has approved Twirla (Agile Therapeutics), a transdermal contraceptive patch containing the estrogen ethinyl estradiol and the progestin levonorgestrel, for use in women with a BMI <30 kg/m2. It is the second contraceptive patch to become available in the US; Xulane, a patch that delivers ethinyl estradiol and the progestin norelgestromin, has been available since 2014.
Med Lett Drugs Ther. 2021 Feb 8;63(1617):17-8 |  Show IntroductionHide Introduction

Estetrol/Drospirenone (Nextstellis) - A New Combination Oral Contraceptive

   
The Medical Letter on Drugs and Therapeutics • Jun 28, 2021  (Issue 1627)
ombitasvir/paritaprevir/ritonavir Renal impairment Adrenal insufficiency 1. Includes women who are >35 ...
The FDA has approved a combination oral contraceptive containing the estrogen estetrol and the progestin drospirenone (Nextstellis – Mithra/Mayne). Estetrol is the first new estrogen to become available in the US in 50 years. Drospirenone is available alone (Slynd) and in combinations with the estrogen ethinyl estradiol for prevention of pregnancy.
Med Lett Drugs Ther. 2021 Jun 28;63(1627):101-2 |  Show IntroductionHide Introduction